February 13, 2018 / 6:26 AM / 11 days ago

BRIEF-Momenta Pharmaceuticals Announces FDA Approval And Launch Of Glatopa

Feb 13 (Reuters) - Momenta Pharmaceuticals Inc:

* MOMENTA PHARMACEUTICALS ANNOUNCES FDA APPROVAL AND LAUNCH OF GLATOPA® (GLATIRAMER ACETATE INJECTION) 40 MG/ML

* MOMENTA PHARMACEUTICALS- U.S. FDA HAS APPROVED SANDOZ‘S ABBREVIATED NEW DRUG APPLICATION FOR GLATOPA (GLATIRAMER ACETATE INJECTION) 40 MG/ML​

* MOMENTA PHARMACEUTICALS - SANDOZ INITIATED LAUNCH OF THE PRODUCT IN U.S.

* MOMENTA PHARMACEUTICALS - GLATOPA WAS DEVELOPED UNDER A COLLABORATION AGREEMENT BETWEEN MOMENTA AND SANDOZ AND IS PRODUCED IN THE US Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below